Mineralys Therapeutics, Inc. - Common Stock (MLYS)

Mineralys Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies to address unmet needs in the treatment of cardiovascular and metabolic diseases

The company specializes in discovering and commercializing novel therapeutics that target mineralocorticoid receptors, a pathway that plays a significant role in regulating blood pressure and fluid balance. Through its cutting-edge research and development efforts, Mineralys aims to improve patient outcomes and enhance quality of life by providing effective solutions for conditions related to hypertension and related disorders.